BALMES TRANSPLANTATION has a total of 13 patent applications. It increased the IP activity by 800.0%. Its first patent ever was published in 2017. It filed its patents most often in France, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, basic materials chemistry and biotechnology are PROXIMAGEN GROUP LTD, CARDIORENTIS LTD and EXLEY RAY W.
# | Country | Total Patents | |
---|---|---|---|
#1 | France | 2 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Singapore | 1 | |
#11 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Basic materials chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Preservation of human bodies | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Berna Patrick | 12 |
#2 | Antetomaso Gwenaelle | 10 |
#3 | Thomas Méryl | 5 |
#4 | Thomas Meryl | 5 |
#5 | Gwenaelle Antetomaso | 1 |
#6 | Patrick Berna | 1 |
#7 | Méryl Thomas | 1 |
Publication | Filing date | Title |
---|---|---|
FR3095755A1 | New cytoprotective drugs | |
FR3073738A1 | NEW CYTOPROTECTIVE MEDICINES |